![]()
Uncorrelated AltsOps 2026
October 29, 2026 | New York City | Club 101
Uncorrelated AltsOps is a premier conference dedicated to the critical role of operations within the alternative investment industry. As the significance of fund operations and operational due diligence continues to rise, this event offers a unique platform for investment managers, investor/allocators, and select industry providers to connect, share insights, and discuss best practices.
This conference will bring together key stakeholders from across the industry to delve into the complexities of operational management, including compliance, risk management, and the evolving regulatory landscape. Attendees will have the opportunity to explore strategies and tools that enhance both operational efficiency and the due diligence processes, making it an essential event for those who are committed to staying ahead in this ever-changing environment.
Uncorrelated AltsOps will feature in-depth panel discussions covering a broad spectrum of topics, Participants will gain actionable insights that can be directly applied to their organizations, helping them to mitigate risks, optimize processes, and ultimately drive better investment outcomes.
Whether you are a fund manager, allocator, or operational professional, Uncorrelated AltsOps is designed to provide you with the knowledge and connections needed to navigate the complexities of alternative investment operations. Join us to engage with peers, share experiences, and contribute to the advancement of operational excellence within the industry.
This is an invite-only event & registration is subject to approval.
If you are interested in attending, please submit a registration request using the Register link above or contact your ROTH Representative.
Conference Agenda
Thursday, October 29, 2026
7:30–8:30 AM
Registration Opens & Breakfast
Location: Foyer & Atrium - Level 1
8:00–8:10 AM
Opening Remarks
Location: Fulton - Level 1
8:15–8:55 AM
Keynote
Scott Levine, Senior Energy & Industrial Analyst at Bloomberg Intelligence
Location: Fulton - Level 1
9:00-10:00 AM
Panel
From Prototype to Profitability - The Commercialization of Nuclear
Presenters: Mike Reinboth, First American Nuclear, Ramsey Hamady, NuScale Power, Rita Baranwal, Radiant Nuclear, Subash Chandra, StoneX
10:10-10:30 AM
Fireside Chat
Deployable Energy (Private)
10:35-10:55 AM
Presentation
ONE Nuclear (Nasdaq: ONEN)
11:00-11:20 AM
Presentation
Deep Isolation (OTCQB: DBHL)
11:25-11:45 AM
Fireside Chat
Radiant Nuclear (Private)
12:00-1:00 PM
Panel
Chains & Cycles: Filling the Gaps of the Nuclear Fuel Cycle
Presenters: Neal Nagarajan, Centrus Energy Corp., Rod Baltzer, Deep Isolation, Subash Chandra, StoneX, Magnus Mori, Urenco
12:00–1:00 PM
Lunch
Location: Atrium - Level 1
1:05-1:25 PM
Fireside Chat
Terra Innovatum (Nasdaq: NKLR)
1:30-1:50 PM
Fireside Chat
Urenco (Private)
1:55-2:15 PM
Fireside Chat
NuCube (Private)
2:20-2:40 PM
Presentation
NuScale (NYSE: SMR)
2:45-3:05 PM
Fireside Chat
Kyoto Fusioneering Ltd (Private)
3:15-3:35 PM
Presentation
Scaled Atomics (Private)
3:40-4:00 PM
Fireside Chat
StarCore Nuclear (Private)
5:00–7:00 PM
Cocktail Reception
Location: Curio Restaurant - Level 2
Venue Location
Frontier X
Private
Frontier X
Private
Frontier X is an early-stage uranium exploration company in Canada. Through BHP Xplor, the company is undertaking a preliminary uranium project focused on testing early geological concepts and building an initial understanding of exploration potential.
Litchfield Minerals
Asx: lms
Litchfield Minerals
Asx: lms
Litchfield Minerals is an Australian exploration company advancing copper, zinc, lead, silver and gold opportunities in the Northern Territory. Through BHP Xplor, the company is focusing on its Oonagalabi project in the Arunta region, applying modern geophysics and targeted fieldwork to better understand a large, underexplored mineral system.
Orion Minerals
ASX: ORN; JSE: ORN
Orion Minerals
ASX: ORN; JSE: ORN
Orion Minerals is a listed exploration and development company advancing a portfolio of copper and zinc assets in South Africa’s Northern Cape. Through BHP Xplor, Orion is applying modern data analytics and mineral systems thinking to identify new discovery opportunities beyond known deposits.
VectOres
Private
VectOres
Private
VectOres Science is a US-based mining technology company developing non-invasive hydrogeochemical and isotopic tools to support mineral exploration. Through BHP Xplor, the company is applying its water and isotope chemistry platform to test how real-time primary data can help identify and prioritise mineral systems earlier, without relying on initial drilling.
No companies match your search.
100%
Employee owned
$100.5B+
Raised for small-cap public companies since 19921.
1 As of November 2, 2023
425+
Merger, acquisitions, advisory assignments since 19921.
![]()
To view Uncorrelated Alts recent news and all upcoming events, please visit uncorrelatedalts.com.
B2I DIGITAL, Inc.is a marketing partner of the 13th Annual ROTH Solar and Storage Symposium at RE+. B2I DIGITAL, Inc. is not an affiliate of ROTH and is not authorized to represent or act on behalf of ROTH, in any capacity. ROTH has not reviewed and approved the content contained on the b2idigital.com website. Content about any specific company was provided and approved by that company or available in the public domain. B2I DIGITAL, Inc. has not independently verified the accuracy of the information contained herein. No content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security.
Explore b2i Digital
B2i Digital partners with conferences like ROTH, Benchmark, Ladenburg Thalmann, OTC Markets, and the NYSE Growth Equity Symposium to connect the online and offline worlds.
Dig into each company's unique story, bios, and filed documents.
Industry experts vetted by B2i, providing hands-on support to active market companies.
From Nasdaq to USA Today, see where client stories land and the audience behind them.
B2i Digital Spotlight
Featured Company
Lakewood-Amedex Biotherapeutics Inc. (Nasdaq: LABT)
Lakewood-Amedex Biotherapeutics Inc. is a clinical-stage biotechnology company developing the Bisphosphocin® class, a novel group of fast-acting, broad-spectrum antimicrobials, to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains including MRSA and VRE.
View CompanyFeatured Conference
Growth Equity Symposium
The NYSE Growth Equity Symposium comes to 11 Wall Street on November 30, 2026. The event features NYSE-led educational programming and networking between investors and emerging growth issuers. The program concludes with a cocktail reception.
View Conference